Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 1;16(1-2):31-32.

Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review

Rajashekar Reddy Yeruva  1   2 , Hema Madhuri Mekala  1   2 , Meesha Sidhu  1   2 , Steven Lippmann  1   2
Affiliations
Review

Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review

Rajashekar Reddy Yeruva et al. Innov Clin Neurosci. .

Abstract

Synthetic cannabinoids, popularly called Spice, are common drugs of abuse in the United States. They are utilized as a substitute for marijuana, primarily for their psychoactive properties. Consumption has been rapidly increasing due to recreational effects, easy accessibility, and not being detectable by urine drug screening tests. The side effect profile of synthetic cannabinoids involves many organs and is not well known to the public. Psychoses are a common adverse result from their consumption. Primary care physicians and other medical professionals should consider synthetic cannabinoid consumption in the differential diagnoses of a patient presenting with psychosis.

Keywords: K2; Spice; adverse events; long-term outcomes; psychosis; schizophrenia; synthetic cannabinoids.

PubMed Disclaimer

Conflict of interest statement

FUNDING:No funding was provided. DISCLOSURES:The authors have no conflicts of interest relevant to the content of this article.

References

    1. Weinstein AM, Rosca P, Fattore L, et al. Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health. Front Psychiatry. 2017;8:156. - PMC - PubMed
    1. Dresen S, Ferreirós N, Pütz M, et al. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom. 2010;45(10):1186–1194. - PubMed
    1. United States Drug Enforcement Administration Department of Justice. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into ScheduleI. Final order. Fed Regist. 2014;79(27):7577–7582. - PubMed
    1. Bloomfield MA, Ashok AH, Volkow ND, et al. The effects of Delta9-tetrahydrocannabinol on the dopamine system. Nature. 2016;539(7629):369–377. - PMC - PubMed
    1. Mathews EM, Jeffries E, Hsieh C, et al. Synthetic cannabinoid use among college students. Addict Behav. 2019;93:219–224. - PubMed

LinkOut - more resources